methylphenidate has been researched along with Cardiovascular Stroke in 15 studies
Methylphenidate: A central nervous system stimulant used most commonly in the treatment of ATTENTION DEFICIT DISORDER in children and for NARCOLEPSY. Its mechanisms appear to be similar to those of DEXTROAMPHETAMINE. The d-isomer of this drug is referred to as DEXMETHYLPHENIDATE HYDROCHLORIDE.
methylphenidate : A racemate comprising equimolar amounts of the two threo isomers of methyl phenyl(piperidin-2-yl)acetate. A central stimulant and indirect-acting sympathomimetic, is used (generally as the hydrochloride salt) in the treatment of hyperactivity disorders in children and for the treatment of narcolepsy.
methyl phenyl(piperidin-2-yl)acetate : A amino acid ester that is methyl phenylacetate in which one of the hydrogens alpha to the carbonyl group is replaced by a piperidin-2-yl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To investigate the association between use of methylphenidate and risk of myocardial infarction among Asians." | 8.02 | Association between methylphenidate and risk of myocardial infarction: A multinational self-controlled case series study. ( Chi, MH; Coghill, D; Hsieh, CY; Jeong, HE; Lai, EC; Lee, H; Liao, TC; Man, KKC; Shin, JY; Wong, ICK, 2021) |
| " In this short communication, we present a case of myocardial infarction in a male likely related to drug interactions between bupropion, erythromycin, and methylphenidate." | 7.73 | Acute myocardial infarction in a young male on methylphenidate, bupropion, and erythromycin. ( Awasthi, A; George, AK; Kunwar, AR, 2005) |
| "Methylphenidate (MPH) is an indirect-acting sympathomimetic drug and structurally related to amphetamine." | 5.72 | Acute myocardial infarction due to spontaneous coronary artery dissection in a 6-year-old boy with ADHD on the third day of treatment with methylphenidate. ( Becker, M; Kerst, G; Ostermayer, S; Pitzer, M; Pohlmann, U; Rascher, W; Stammschulte, T, 2022) |
| "Adult Attention Deficit Disorder is increasingly diagnosed and treated." | 5.36 | Acute myocardial infarction related to methylphenidate for adult attention deficit disorder. ( Thompson, J; Thompson, JR, 2010) |
| "To investigate the association between use of methylphenidate and risk of myocardial infarction among Asians." | 4.02 | Association between methylphenidate and risk of myocardial infarction: A multinational self-controlled case series study. ( Chi, MH; Coghill, D; Hsieh, CY; Jeong, HE; Lai, EC; Lee, H; Liao, TC; Man, KKC; Shin, JY; Wong, ICK, 2021) |
| " This case should be borne in mind before a diagnosis of myocardial infarction is given, or a decision to perform invasive coronary angiography is made in patients that use methylphenidate or related substances." | 3.80 | Myocardial injury in a 41-year-old male treated with methylphenidate: a case report. ( Hole, LD; Schjøtt, J, 2014) |
| " In this short communication, we present a case of myocardial infarction in a male likely related to drug interactions between bupropion, erythromycin, and methylphenidate." | 3.73 | Acute myocardial infarction in a young male on methylphenidate, bupropion, and erythromycin. ( Awasthi, A; George, AK; Kunwar, AR, 2005) |
| "Methylphenidate (MPH) is an indirect-acting sympathomimetic drug and structurally related to amphetamine." | 1.72 | Acute myocardial infarction due to spontaneous coronary artery dissection in a 6-year-old boy with ADHD on the third day of treatment with methylphenidate. ( Becker, M; Kerst, G; Ostermayer, S; Pitzer, M; Pohlmann, U; Rascher, W; Stammschulte, T, 2022) |
| "Methylphenidate is an important element of therapeutic strategies for ADHD." | 1.40 | [Cardiovascular risks and management during Attention Deficit Hyperactivity Disorder treatment with methylphenidate]. ( Acquaviva, E; Bange, F; Delorme, R; Le Heuzey, MF; Mouren, MC, 2014) |
| " Dosage was inversely associated with risk." | 1.38 | Methylphenidate and risk of serious cardiovascular events in adults. ( Bilker, WB; Cziraky, MJ; Daniel, GW; Guevara, JP; Hennessy, S; Kimmel, SE; Newcomb, C; Schelleman, H; Strom, BL, 2012) |
| "Adult Attention Deficit Disorder is increasingly diagnosed and treated." | 1.36 | Acute myocardial infarction related to methylphenidate for adult attention deficit disorder. ( Thompson, J; Thompson, JR, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (6.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (6.67) | 29.6817 |
| 2010's | 10 (66.67) | 24.3611 |
| 2020's | 3 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Seeley, SL | 1 |
| D'Souza, MS | 1 |
| Stoops, TS | 1 |
| Rorabaugh, BR | 1 |
| Stammschulte, T | 1 |
| Pitzer, M | 1 |
| Rascher, W | 1 |
| Becker, M | 1 |
| Pohlmann, U | 1 |
| Ostermayer, S | 1 |
| Kerst, G | 1 |
| Jeong, HE | 1 |
| Lee, H | 1 |
| Lai, EC | 1 |
| Liao, TC | 1 |
| Man, KKC | 1 |
| Wong, ICK | 1 |
| Coghill, D | 1 |
| Chi, MH | 1 |
| Hsieh, CY | 1 |
| Shin, JY | 1 |
| Bange, F | 1 |
| Le Heuzey, MF | 1 |
| Acquaviva, E | 1 |
| Delorme, R | 1 |
| Mouren, MC | 1 |
| Hole, LD | 1 |
| Schjøtt, J | 1 |
| Hay, E | 1 |
| Shklovski, V | 1 |
| Blaer, Y | 1 |
| Shlakhover, V | 1 |
| Katz, A | 1 |
| Wassef, N | 1 |
| Khan, N | 1 |
| Munir, S | 1 |
| Hennessy, S | 2 |
| Schelleman, H | 2 |
| Daniel, GW | 2 |
| Bilker, WB | 2 |
| Kimmel, SE | 2 |
| Guevara, J | 1 |
| Cziraky, MJ | 2 |
| Strom, BL | 2 |
| Kratochvil, CJ | 1 |
| Newcomb, C | 1 |
| Guevara, JP | 1 |
| Ruwald, MH | 1 |
| Ruwald, AC | 1 |
| Tønder, N | 1 |
| Harbeck, C | 1 |
| BRACHFELD, J | 1 |
| MYERSON, RM | 1 |
| George, AK | 1 |
| Kunwar, AR | 1 |
| Awasthi, A | 1 |
| Thompson, J | 1 |
| Thompson, JR | 1 |
15 other studies available for methylphenidate and Cardiovascular Stroke
| Article | Year |
|---|---|
Short term methylphenidate treatment does not increase myocardial injury in the ischemic rat heart.
Topics: Animals; Central Nervous System Stimulants; Disease Models, Animal; Drug Administration Schedule; Fe | 2020 |
Acute myocardial infarction due to spontaneous coronary artery dissection in a 6-year-old boy with ADHD on the third day of treatment with methylphenidate.
Topics: Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Coronary Ve | 2022 |
Association between methylphenidate and risk of myocardial infarction: A multinational self-controlled case series study.
Topics: Hong Kong; Humans; Methylphenidate; Myocardial Infarction; Prescriptions; Research Design | 2021 |
[Cardiovascular risks and management during Attention Deficit Hyperactivity Disorder treatment with methylphenidate].
Topics: Attention Deficit Disorder with Hyperactivity; Blood Pressure; Central Nervous System Stimulants; Ch | 2014 |
Myocardial injury in a 41-year-old male treated with methylphenidate: a case report.
Topics: Adult; Chest Pain; Humans; Male; Methylphenidate; Myocardial Infarction; Tachycardia, Supraventricul | 2014 |
Intravenous methylphenidate: an unusual way to provoke ST-elevation myocardial infarction.
Topics: Adult; Central Nervous System Stimulants; Electrocardiography; Emergency Service, Hospital; Heart; H | 2015 |
Quetiapine-induced myocarditis presenting as acute STEMI.
Topics: Adolescent; Antipsychotic Agents; Attention Deficit Disorder with Hyperactivity; Bipolar Disorder; C | 2015 |
Cardiovascular safety of ADHD medications: rationale for and design of an investigator-initiated observational study.
Topics: Adolescent; Adrenergic Uptake Inhibitors; Amphetamines; Atomoxetine Hydrochloride; Attention Deficit | 2010 |
ADHD pharmacotherapy: rates of stimulant use and cardiovascular risk.
Topics: Attention Deficit Disorder with Hyperactivity; Blood Pressure; Central Nervous System Stimulants; De | 2012 |
Methylphenidate and risk of serious cardiovascular events in adults.
Topics: Adult; Aged; Central Nervous System Stimulants; Cohort Studies; Databases, Factual; Death, Sudden, C | 2012 |
[Methylphenidate induced ST elevation acute myocardial infarction].
Topics: Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Coronary Vasospasm | 2012 |
[Misleading case report of heart problems by methylphenidate].
Topics: Central Nervous System Stimulants; Humans; Male; Methylphenidate; Myocardial Infarction | 2012 |
TREATMENT OF CARDIOGENIC SHOCK AND VASOPRESSOR DEPENDENCY WITH INTRAVENOUS METHYLPHENIDATE (RITALIN).
Topics: Cardiomegaly; Drug Therapy; Geriatrics; Heart Failure; Humans; Hypotension; Methylphenidate; Myocard | 1965 |
Acute myocardial infarction in a young male on methylphenidate, bupropion, and erythromycin.
Topics: Adolescent; Anti-Bacterial Agents; Antidepressive Agents, Second-Generation; Bupropion; Central Nerv | 2005 |
Acute myocardial infarction related to methylphenidate for adult attention deficit disorder.
Topics: Adult; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Coronary Va | 2010 |